Piperidine Market Size was valued at USD 0.06 Billion in 2022. The Piperidine industry is projected to grow from USD 0.07 Billion in 2023 to USD 0.29 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 18.72% during the forecast period (2023 - 2032). Growing industrialization and increasing demand in the pharmaceutical sector are the key market drivers boosting the expansion of the market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Market CAGR for Piperidine is being driven by the growing demand from the pharmaceutical sector. One important and broad class of nitrogen-bearing heterocyclic molecules are piperidine derivatives. Piperidine-containing compounds exhibit a broad range of biological actions. One essential ingredient in the creation of many medications is piperidine. Antipsychotic, analgesic, anti-inflammatory, anticancer, and antibacterial medications all make extensive use of them. Complexes of pyridine and piperidine are two of the most prevalent heterocyclic fragments found in FDA-approved medications.
Additionally, Chronic illnesses like diabetes, cancer, hepatitis, asthma, chronic obstructive pulmonary disease (COPD), coronary artery disease, arthritis, and hepatitis have become much more common in major parts of the world during the past few decades. This can be linked to the world's aging population, shifting lifestyles, and altered diets brought on by fast urbanization. There is a rising need for APIs to effectively treat chronic diseases due to their high incidence and prevalence. Leading companies in the industry are concentrating on expanding their production facilities in order to increase their production capacity for APIs specifically designed to treat chronic diseases, as well as orienting their portfolios of API products toward therapies for chronic diseases that are becoming more prevalent.
A key ingredient in the manufacture of pharmaceuticals is piperidine. It exhibits a number of traits and is used as an analgesic, antipsychotic, anticancer, and antibacterial drug in various contexts. For the treatment of cancer, there are currently over a hundred chemotherapy drugs with medical approval. Nonetheless, the majority of anticancer medications' toxicological information has limited their use as antiproliferative medications. It has been discovered that a number of piperidine alkaloids, including Tetrandine, Evodiamine, Matrine, Berberine, and Piperine, that are extracted from natural herbs have antimetastatic and antiproliferation properties on a variety of cancer types both in vitro and in vivo. Pyridine is hydrogenated to produce piperidine. Typically, a molybdenum disulfide catalyst is used in this process. Two important factors in the piperidine market's value chain are the cost and accessibility of raw materials.
For instance, In August 2021, Vasudha Pharma Chem Limited (VPCL) retained its Long-Term Issuer Rating of 'IND A+' according to India Ratings and Research. In addition to maintaining long-term relationships with important clients, VPCL has more than 20 years of experience producing pharmaceutical intermediates and active pharmaceutical ingredients (APIs). A significant amount of VPCL's sales are derived from large, long-standing domestic and foreign pharmaceutical companies, mostly from its core chemicals. Thus, result in driving the Piperidine market revenue.
The Piperidine market segmentation, based on type includes 99% Purity, and 98% Purity. The 98% Purity segment dominated the market. Agrochemicals, rubber production, organic synthesis, and other uses are the primary uses for 98% pure piperidine. Piperidine is utilized in agrochemicals as a catalyst, solverit, base, or other processing assistance throughout the manufacturing process, or it can be included in the final active ingredient.
The Piperidine market segmentation, based on End Use Industry, includes Pharmaceutical, Agrochemicals, Rubber, and Others. The Pharmaceutical category generated the most income. Piperidine is an essential ingredient in the production of several medicinal medicines. The nitrogen-bearing heterocyclic ring structure found in piperidine and its derivatives is primarily utilized in the synthesis of several medications, including antipsychotic, analgesic, anticancer, and antibacterial medicines.
Figure1: Piperidine Market, by End Use Industry,2022&2032(USD Billion)
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American Piperidine market area will dominate this market, because piperidine is in high demand as a raw ingredient for medication synthesis in the strong and expanding pharmaceutical sector. Piperidine-based chemicals are highly needed in the creation of various pharmaceuticals, especially those used to treat chronic disorders, as the region is a center for pharmaceutical research and development.
Further, the major countries studied in the market report are The US, German, France, the UK, Canada, Italy, Spain, India, Australia, South Korea, China, Japan, and Brazil.
Figure2:PIPERIDINE MARKET SHARE BY REGION 2022 (USD Billion) 
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Europe Piperidine market has the second-largest portion of the market because of the government's economic development measures and the rapid economic development. Further, the German Piperidine market had the biggest market share, and the UK Piperidine market was the fastest growing market in the European region
The Asia-Pacific Piperidine Market is anticipated to expand between 2023 and 2032 at the quickest CAGR. The need for pharmaceuticals to address healthcare issues, such as an increasing number of people with chronic diseases, is growing as the region's economies expand. Moreover, China’s Piperidine market had the biggest market share, and the Indian Piperidine market was the fastest growing market in the Asia-Pacific region.
Leading market players are putting a lot of money on R&D to expand their product lines, which will help the market for weight reduction products grow. Additionally, market players are engaging in a range of calculated initiatives to increase their worldwide presence, with important market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. to grow and endure in an increasingly cutthroat and dynamic market, Piperidine industry must provide reasonably priced goods.
Manufacturing locally is one of the primary business techniques used by manufacturers to cut operational costs in the Piperidine industry to help customers and expand the market segment. In recent years, the Piperidine industry has provided some of the biggest benefits to medicine. Major players in the Piperidine market, including BASF SE (Germany), Koei Chemical Co. Ltd. (Japan), Vertellus (US), Jubilant Ingrevia Limited (India), Vasudha Pharma (India)., and others, are attempting to increase market demand by investing in research and development operations.
BASF SE, a multinational corporation based in Europe and the world's largest chemical producer, was formerly known as Badische Anilin- und Sodafabrik. Ludwigshafen, Germany, is home to the company's headquarters. BASF operates 6 integrated production sites and 390 smaller manufacturing sites throughout Europe, Asia, Australia, the Americas, and Africa. Its subsidiaries and joint ventures are spread across more than 80 countries. Supplying products to a broad range of industries, BASF has clients in more than 190 countries. BASF has garnered minimal public notice despite its reach and magnitude since it stopped producing and marketing consumer electronics items bearing the BASF trademark in the 1990s. In September 2019, BASF and DuPont Safety & Construction, a division of DuPont Co., reached an agreement for the sale of BASF's ultrafiltration membrane company, Inge GmbH.
The Merck Group, which goes by the brand name Merck, is a multinational science and technology firm based in Darmstadt, Germany. It employs over 60,000 people and operates in 66 countries. About 250 businesses make up the group, with Merck KGaA in Germany serving as the leader. Healthcare, Life Sciences, and Electronics are the three business segments that make up the organization. Having been established in 1668, Merck is the oldest chemical and pharmaceutical firm in the world and among the biggest in the world. In February 2020, Merck declared that it would be selling its Allergopharma business to Dermapharm for an undisclosed sum.
BASF SE (Germany)
Koei Chemical Co. Ltd. (Japan)
Vertellus (US)
Jubilant Ingrevia Limited (India)
Vasudha Pharma (India)
Taj Pharmaceuticals Ltd. (India)
Avantor Inc. (US)
Allchem Lifescience Pvt. Ltd. (India)
Toronto Research Chemicals (Canada)
Merck KGaA (Germany),
In May 2022, Avantor, Inc. revealed its establishment of a new manufacturing plant as well as distribution center in Singapore It is a new facility to be situated in Singapore. This will enable the company to solve issues related to capacity by expanding its manufacturing capabilities while still using the already available distribution facilities. The unit will start operation in 2023 with an emphasis on extending market coverage within Asia-Pacific.
Vasudha Pharma Chem Limited's Long-Term Issuer Rating was reaffirmed at 'IND A+' by India Ratings and Research on August 05, 2021. VPCL has more than twenty years’ experience producing active pharmaceutical ingredients (APIs) pharma intermediates in contract manufacturing. It enjoys long-term relationships with its key customers. A large percentage of these sales comes from large domestic & multinational pharma companies that have been dealing with VPCL for several years, mainly due to certain core molecules manufactured by it. These primary segments have seen consistent demand for the past five years and are expected to continue having this trend in the medium-term period as well. In addition, there are many other causes for success, as mentioned above.
Alongside Vasudha Pharma Chem Limited, other players like MilliporeSigma also thrive in piperidine derivatives production within the industrial sector. For instance, Vasudha Pharma, which is based out of India, makes Piperidine intermediates/as well as APIs for the global pharmaceutical industry. Similarly, Merck subsidiary MilliporeSigma continues to innovate in chemical synthesis, including piperidine-based product development.
June 2024 witnessed some significant developments regarding Piperidine in both the pharmaceutical and chemical industries. Notably among these was the synthesis of a series of crizotinib-resistant anaplastic lymphoma kinase (ALK) and c-ros oncogene one kinase (ROS1) inhibitors, piperidine derivatives. These derivatives show promise in treating various cancers, including non-small cell lung cancer and neuroblastoma.
99% Purity
98% Purity
Pharmaceutical
Agrochemicals
Rubber
Others
| Report Attribute/Metric | Details |
| Market Size2022 | USD 0.06 Billion |
| Market Size 2023 | USD 0.07 Billion |
| Market Size2032 | USD 0.29 Billion |
| Compound Annual Growth Rate (CAGR) | 18.72% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, End Use Industry, and Region |
| Geographies Covered | North America, Europe, AsiaPacific, and the Rest of the World |
| Countries Covered | The US, German, France, UK, Canada, Italy, Spain, India, Australia, South Korea, China, Japan, and Brazil |
| Key Companies Profiled | BASF SE (Germany), Koei Chemical Co. Ltd. (Japan), Vertellus (US), Jubilant Ingrevia Limited (India), Vasudha Pharma (India) |
| Key Market Opportunities | Piperidine and its derivatives' emergence as antimetastatic and antiproliferative medications. |
| Key Market Dynamics | Growing demand from the pharmaceutical sector |
Piperidine Market Highlights:
Frequently Asked Questions (FAQ) :
In 2022, the piperidine market was estimated to be worth USD 0.06 billion globally.
From 2023 to 2032, the market is expected to expand at a compound annual growth rate (CAGR) of 18.72%.
North America held the most market share worldwide.
The leading companies in the market are Vasudha Pharma (India), Jubilant Ingrevia Limited (India), Vertellus (US), Koei Chemical Co. Ltd. (Japan), and BASF SE (Germany).
In 2022, the market was dominated by the 98% Purity category.
The pharmaceutical industry held the biggest market share worldwide.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Team Lead - Research Anshula mandaokar holds an academic degree in chemical engineering and has been contributing to the field for more than 5 years. she has expertise in market research and business consulting and serves as a team lead for a reputed market research firm under the chemicals and materials domain spectrum. she has worked on multiple projects, generating explicit results in a quick turnaround time. her understanding of data interpretation justifies her role as a leader.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
